Trial Details
UNKNOWNBasic Information
| Clinical ID | c796 |
|---|---|
| Identifier | NCT06033469 |
| Trial Title | Therapeutic Monitoring of Infliximab and Adalimumab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Infliximab|DRUG: Adalimumab |
Participant Information
| Sponsor | IRCCS Burlo Garofolo |
|---|---|
| City | Bologna |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2018-03-15 |
|---|---|
| Primary Completion Date | 2024-06-30 |
| Completion Date | 2024-06-30 |